CM037
CM037 is a highly selective and competitive ALDH1A1 inhibitor (IC50=4.6 μM) . CM037 blocks the catalytic activity of ALDH1A1, thereby inhibiting the activation of the downstream HIF-1α/VEGF pathway. CM037 is mainly used to study the ALDH1A1-mediated regulation of cancer stem cells (CSCs) and angiogenesis, especially in breast cancer, showing the potential to inhibit tumor angiogenesis and stem cell characteristics[1][2].
Product Specifications
CAS Number
896795-60-1
Product Name Alternative
A37
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Aldehyde Dehydrogenase (ALDH)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cm037.html
Purity
99.55
Solubility
DMSO : 83.33 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C1C2=C(N=C(SCC(OCC)=O)N1CCCN3CCCC3)C4=CC=CC=C4S2
Molecular Formula
C21H25N3O3S2
Molecular Weight
431.57
Precautions
H302, H315, H319
References & Citations
[Content Brief]
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
ALDH1
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![4-Bromo-3,5-dihydro-pyrrolo[3,4-c]pyrrol-1(2H)-one](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
4-Bromo-3,5-dihydro-pyrrolo[3,4-c]pyrrol-1(2H)-one